Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans (Q34348095)

1 August 2017

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans (English)

1 reference

1 August 2017

10

1 reference

1 August 2017

J Licinio

1

0 references

author name string

F O'Kirwan

2

1 reference

1 August 2017

K Irizarry

3

1 reference

1 August 2017

B Merriman

4

1 reference

1 August 2017

S Thakur

5

1 reference

1 August 2017

R Jepson

6

1 reference

1 August 2017

S Lake

7

1 reference

1 August 2017

K G Tantisira

8

1 reference

1 August 2017

S T Weiss

9

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

1 August 2017

1 reference

1 August 2017

9

1 reference

1 August 2017

12

1 reference

1 August 2017

1075-1082

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001587

1 August 2017

0 references

cites work

Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

CRF and CRF receptors: role in stress responsivity and other behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Score tests for association between traits and haplotypes when linkage phase is ambiguous

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Minimal haplotype tagging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

21 January 2018

THE HARDY-WEINBERG LAW.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Identification of hypothalamic transcripts upregulated by antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Research and treatment approaches to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Cytokines and depression: fortuitous or causative association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Atopy and depression: results from the Northern Finland 1966 Birth Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Data from the Northern Finland 1966 Birth Cohort support an association between depression and immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Corticotropin-releasing hormone antagonists possess anti-inflammatory effects in the mouse ileum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

The immune system, depression and the action of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Effects of antidepressants on cytokine production and actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

The pharmacogenomics of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

Cortisol production in depressive illness. A clinical and biochemical clarification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

A comparison of three indicators for identifying Mexican Americans in epidemiologic research. Methodological findings from the San Antonio Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001587

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001587

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference